Abstract:Abstract: Many drugs have adverse absorption, distribution, metabolism, and excretory (ADME) properties that prevent their widespread use or limit their use in some indications. In addition to preparation techniques and prodrug strategies, deuterium modification is a viable method for improving ADME properties. Deuterated drugs have attracted increasing attention from the pharmaceutical industry in recent years. To date, two deuterated drugs have been approved by the FDA. In 2017, austedo was approved by the FDA as a new drug for Huntington's disease in the United States, the first deuterium drug to be marketed worldwide. Recently (June 9, 2021), donafinil has been listed in China; this result has caused major pharmaceutical companies and the pharmaceutical industry to pay attention to deuterium technology again. In addition, BMS-986165, RT001, ALK-001, HC-1119, AVP-786 and other drugs are in phase III clinical studies, and some solid deuterium compounds have entered phase I and IIclinical trials. The deuterium strategy has been widely used in pharmaceutical research and has become a hot spot in pharmaceutical research in recent years. In this paper, the research and development of deuterated drugs are reviewed, and the influence of deuterium modification on drugs, the advantages of deuterium strategies and the synthesis strategies of deuterated drugs are mainly introduced. Hoping to provide references for clinical application, the discovery of new deuterium chemical entities and research and development of new deuterated drugs.

Deuterated reagents in multicomponent reactions to afford deuterium-labeled products

Efficient Brønsted‐Acid‐Catalyzed Deuteration of Arenes and Their Transformation to Functionalized Deuterated Products

Versatile Regioselective Deuteration of Indoles Via Transition-Metal-Catalyzed H/D Exchange

The Kinetic Isotope Effect in the Search for Deuterated Drugs

Stereodefined Rhodium-Catalysed 1,4-H/D Delivery for Modular Syntheses and Deuterium Integration

Selective Deuteration and Tritiation of Pharmaceutically Relevant Sulfoximines

Deuterated Alkyl Sulfonium Salt Reagents; Importance of H/D Exchange Methods in Drug Discovery

Rational Design of Biocatalytic Deuteration Platform of Aldehydes

Designing chemical systems for precision deuteration of medicinal building blocks

Deuterium Editing of Small Molecules: A Case Study on Antitumor Activity of 1,4-Benzodiazepine-2,5-dione Derivatives

Recent Advances in Deuteration Reactions

Clinical Application and Synthesis Methods of Deuterated Drugs

Catalytic Transfer Deuteration and Hydrodeuteration: Emerging Techniques to Selectively Transform Alkenes and Alkynes to Deuterated Alkanes.

Alkali Metal Amide–Catalyzed Deuteration and Tritiation of Pharmaceuticals

Deuterated-Alkylation Reagents based on Sulfonium Salts as Cation and Radical Sources

Photocatalytic and highly regioselective H/D exchange at alpha-thio C(sp3)-H bonds

Hydrodeuteroalkylation of Unactivated Olefins Using Thianthrenium Salts

Deuteration and Tritiation of Pharmaceuticals by Non-Directed Pd Catalyzed C–H Activation in Heavy and Super-Heavy Water

Catalyst-free decarboxylative deuteration using tailored photoredox-active carboxylic acids

Robust whole‐cell‐based chemoenzymatic synthesis of site‐selective deuterated α‐hydroxy acids and α‐amino acids

Electrolytic deuteration of unsaturated bonds without using D2